Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Am J Gastroenterol ; 117(3): 433-444, 2022 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-35083985

RESUMO

INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is one of the most common etiologies of liver transplantation (LT) in the United States. We investigated regional trends in waitlist candidates, LT rates, and recipient survival among patients with NASH. METHODS: Using the United Network for Organ Sharing database by Organ Procurement and Transplantation Network regions, we investigated waitlist registration, LT rates, and survival for NASH between January 2004 and December 2019. RESULTS: The absolute number and percentage of total LT performed for NASH increased substantially in all Organ Procurement and Transplantation Network regions. In 2019, region 11 had the highest percentage of NASH-related LT with 31.4% followed by region 10 (25.3%) and region 8 (23.1%). Between 2015 and 2019, region 5 had the highest rising percentage in LT for NASH at 208%, followed by region 1 (194%) and region 4 (183%). The proportion of NASH hepatocellular carcinoma (NASH-HCC) was the highest in region 9 at 37.7% and lowest in region 10 (19.2%), region 3 (20.6%), and region 11 (20.8%). In multivariate analysis, diabetes (HR 1.18, P < 0.001), dialysis before LT (hazard ratio [HR] 1.53, P < 0.001), HCC (HR 1.19, P < 0.00), portal vein thrombosis (HR 1.24, P < 0.001), donor age (HR 1.026, P = 0.03), and recipient age (HR 1.24, P = <0.001) were associated with worse survival. DISCUSSION: LT for patients with NASH has dramatically increased across all regions since 2004, but with substantial heterogeneity among regions in the proportion with HCC and post-LT survival. Identifying contributing factors to these regional differences is warranted.


Assuntos
Carcinoma Hepatocelular , Neoplasias Hepáticas , Transplante de Fígado , Hepatopatia Gordurosa não Alcoólica , Carcinoma Hepatocelular/epidemiologia , Carcinoma Hepatocelular/cirurgia , Humanos , Hepatopatia Gordurosa não Alcoólica/epidemiologia , Hepatopatia Gordurosa não Alcoólica/cirurgia , Estudos Retrospectivos , Fatores de Risco , Estados Unidos/epidemiologia
2.
Am J Public Health ; 111(11): 2019-2026, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34648382

RESUMO

Objectives. To compare the severity of inpatient hospitalizations between undocumented immigrants and Medi-Cal patients in a large safety-net hospital in Los Angeles, California. Methods. We conducted a retrospective analysis of all 2019 inpatient stays at a Los Angeles hospital (n = 22 480), including patients of all races/ethnicities. We examined 3 measures by using insurance status to approximate immigration status: illness severity, length of hospital stay, and repeat hospitalizations. We calculated group differences between undocumented and Medi-Cal patients by using inverse probability weighted regression adjustment separately for patients aged 18 to 64 years and those aged 65 years and older. Results. Younger undocumented patients had less severe illness and shorter lengths of stay than their Medi-Cal counterparts. Older undocumented immigrants also had less severe illness, but had similar lengths of stay and were more likely to have repeated hospitalizations. Conclusions. While existing work suggests that undocumented immigrants could have more severe health care needs on account of their poorer access to medical care, we did not see clear health disadvantages among hospitalized undocumented immigrants, especially younger patients. There were fewer differences between undocumented and Medi-Cal patients who were older. (Am J Public Health. 2021;111(11):2019-2026. https://doi.org/10.2105/AJPH.2021.306485).


Assuntos
Hospitalização/estatística & dados numéricos , Imigrantes Indocumentados , Adolescente , Adulto , Idoso , Feminino , Acessibilidade aos Serviços de Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Cobertura do Seguro , Tempo de Internação/estatística & dados numéricos , Los Angeles , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença , Planos Governamentais de Saúde
4.
Clin Liver Dis (Hoboken) ; 19(3): 106-110, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35355841

RESUMO

Content available: Author Audio Recording.

5.
BMJ Case Rep ; 11(1)2018 Dec 27.
Artigo em Inglês | MEDLINE | ID: mdl-30593526

RESUMO

Syphilis is a sexually transmitted disease that can affect multiple organ systems, with central nervous system involvement at any stage. We present a 53-year-old woman with an unusual truncal rash with painful anogenital lesions, accompanied by patchy alopecia, oral lesions, photophobia and hoarseness. She was found to have positive serological tests for syphilis with cerebrospinal fluid findings suggestive of neurosyphilis. She underwent a 14-day course of intravenous penicillin G and exhibited successful resolution of painful anogenital lesions as well as marked improvement in dermatological, oropharyngeal, laryngeal, and neurological symptoms.


Assuntos
Rouquidão/diagnóstico , Neurossífilis/diagnóstico , Sífilis Cutânea/diagnóstico , Alopecia/complicações , Alopecia/diagnóstico , Alopecia/tratamento farmacológico , Alopecia/patologia , Antibacterianos/uso terapêutico , Doenças do Ânus/complicações , Doenças do Ânus/diagnóstico , Doenças do Ânus/tratamento farmacológico , Doenças do Ânus/patologia , Feminino , Cefaleia/etiologia , Rouquidão/tratamento farmacológico , Rouquidão/etiologia , Humanos , Doenças da Laringe/complicações , Doenças da Laringe/diagnóstico , Doenças da Laringe/tratamento farmacológico , Pessoa de Meia-Idade , Doenças da Boca/complicações , Doenças da Boca/diagnóstico , Doenças da Boca/tratamento farmacológico , Doenças da Boca/patologia , Neurossífilis/líquido cefalorraquidiano , Neurossífilis/complicações , Neurossífilis/tratamento farmacológico , Palato Duro , Penicilina G/uso terapêutico , Fotofobia/etiologia , Sífilis Cutânea/tratamento farmacológico , Sífilis Cutânea/patologia , Doenças da Vulva/complicações , Doenças da Vulva/diagnóstico , Doenças da Vulva/tratamento farmacológico , Doenças da Vulva/patologia
6.
LGBT Health ; 4(5): 371-375, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28876170

RESUMO

PURPOSE: Both hormone therapy (HT) and antiretroviral therapy (ART) can be lifesaving for transgender women (TW) living with HIV, but each has side effects and potential drug-drug interactions (DDI). We assessed how concerns about HT-ART interactions affect treatment adherence. METHODS: This study used a cross-sectional survey of TW (n = 87) in Los Angeles, CA. RESULTS: Fifty-four percent were living with HIV; 64% used HT. Only 49% of TW living with HIV discussed ART-HT DDI with their provider; 40% reported not taking ART (12%), HT (12%), or both (16%) as directed due to DDI concerns. CONCLUSION: Imperfect HT/ART use and limited provider communication suggests a need for improved HT-ART integration.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Interações Medicamentosas , Infecções por HIV/tratamento farmacológico , Terapia de Reposição Hormonal , Adesão à Medicação , Pessoas Transgênero , Estudos Transversais , Feminino , Humanos , Los Angeles , Masculino , Adesão à Medicação/estatística & dados numéricos , Pessoa de Meia-Idade , Projetos Piloto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA